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Introduction
About 5% of all patients suffering acute pulmonary embo-
lism will develop chronic thrombembolic pulmonary
hypertension (CTEPH). This in turn causes continuous
detoriation of right ventricular function. Pulmonary
thrombendarterectomy (PEA) is a possible cure of this
condition with favourable long term prognosis. Cardiac
magnetic resonance imaging (cMRI) is an excellent tool
for measurement of right ventricular volumes and func-
tion.
Purpose
This study seeks to determine the changes of right ven-
tricular geometry before and after PEA by cMRI and ist
accuracy compared to invasive measurements.
Methods
19 patients (age 64 ± 23) underwent CINE TruFISP MRI
(1.5 T, Siemens Sonata) 2 days before and 10 ± 1 days
after PEA. Volumetric analysis was performed on 10 con-
tiguous short axis slices covering the whole right ventricle
with the Siemens Argus Tool. Ejection Fraction (RVEF),
Enddiastolic (RVEDV)-, Endsystolic (RVESV)- and stroke
(RVSV) volumes as well as right ventricular mass
(RVMass) were computed. RVSV and RVEF measurements
were correlated with pre- and postoperative invasive
measurements of cardiac outpout (CO) by PA-catheter.
Results
Noninvasive measurements of RVSV and RVEF showed
good correlation with invasive CO measures (r = 0.6, p =
0.018 for SV and r = 0.66, p = 0.019 for EF). RVEF, RVEDV
and RVESV improved significantly over time while
RVMass remained unchanged (RVEF from 18.6 ± 4.3 to
41.6 ± 11.5 p = 0.008, RVEDV from 200.4 ± 30.7 to 145.3
± 33.2 p = 0.0001, RVESV from 163 ± 25.6 to 82.9 ± 14.9
p = 0.001, RVMass from 83.5 ± 16.3 to 68.9 ± 15.1 p =
0.18).
Conclusion
cMRI measurement showed good accuracy compared
with PA-cath measurements. It is an excellent tool to doc-
ument acute changes of RV-function and volumes before
and after PEA. It shows immediate and significant
improvement of both right ventricular function and vol-
umes.
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